Key Decisions and Financial Results

The Board of Directors of Eureka Forbes Limited at its meeting held on Monday, November 02, 2026, which commenced at 12:27 PM IST and concluded at 01:20 PM IST, considered and approved the following items:

1. Approval of Financial Results: The unaudited Standalone and Consolidated Financial Results for the Quarter and Half Year ended September 30, 2026, along with the Limited Review Report (LRR) issued by the statutory auditors, Deloitte Haskins & Sells LLP.

2. Re-appointment of Director: The re-appointment of Mr. Homi Katgara (DIN: 00210338) as a Non-Executive, Independent Director for a second term of 5 consecutive years, commencing from January 31, 2027, to January 30, 2032, subject to the approval of the company's members.

Detailed Standalone Financial Performance (in ₹ Lakhs)

Quarterly Performance (Q2 FY27 vs. Q2 FY26 vs. Q1 FY27)

  • Revenue from Operations: ₹8,895.91 in Q2 FY27 vs. ₹7,734.49 in Q2 FY26 (15.0% growth) and ₹7,007.67 in Q1 FY27.
  • Total Income: ₹8,957.00 in Q2 FY27 vs. ₹7,793.18 in Q2 FY26 and ₹7,079.56 in Q1 FY27.
  • Profit Before Exceptional Items & Tax: ₹980.88 in Q2 FY27 vs. ₹831.64 in Q2 FY26 and ₹548.98 in Q1 FY27.
  • Exceptional Items - Income: ₹195.38 lakhs recorded in Q2 FY27 (gratuity reversal). No exceptional items in Q2 FY26 or Q1 FY27.
  • Profit Before Tax: ₹980.88 in Q2 FY27 vs. ₹831.64 in Q2 FY26 and ₹744.36 in Q1 FY27.
  • Profit After Tax: ₹733.39 in Q2 FY27 vs. ₹615.89 in Q2 FY26 (19.1% growth) and ₹554.36 in Q1 FY27.
  • Total Comprehensive Income: ₹712.39 in Q2 FY27 vs. ₹607.30 in Q2 FY26 and ₹533.37 in Q1 FY27.
  • Basic & Diluted EPS (₹): 3.77 in Q2 FY27 vs. 3.17 in Q2 FY26 and 2.85 in Q1 FY27.

Half-Yearly Performance (H1 FY27 vs. H1 FY26)

  • Revenue from Operations: ₹15,903.59 in H1 FY27 vs. ₹13,811.90 in H1 FY26 (15.1% growth).
  • Total Income: ₹16,036.56 in H1 FY27 vs. ₹13,941.99 in H1 FY26.
  • Profit Before Exceptional Items & Tax: ₹1,529.87 in H1 FY27 vs. ₹1,348.56 in H1 FY26.
  • Exceptional Items - Income: ₹195.38 lakhs recorded in H1 FY27 (gratuity reversal). Exceptional expense of ₹404.42 lakhs in FY26 (full year).
  • Profit Before Tax: ₹1,725.24 in H1 FY27 vs. ₹1,348.56 in H1 FY26.
  • Profit After Tax: ₹1,287.75 in H1 FY27 vs. ₹983.94 in H1 FY26 (30.9% growth).
  • Total Comprehensive Income: ₹1,245.76 in H1 FY27 vs. ₹1,002.01 in H1 FY26.
  • Basic & Diluted EPS (₹): 6.62 in H1 FY27 vs. 5.15 in H1 FY26.

Key Balance Sheet Items (Standalone) as of September 30, 2026

  • Paid-up Share Capital: ₹1,936.37 lakhs (Face value ₹10 each)
  • Reserves: ₹43,795.44 lakhs
  • Total Assets: ₹71,121.81 lakhs (vs. ₹67,019.47 lakhs on Mar 31, 2026)
  • Total Equity: ₹47,157.63 lakhs
  • Total Liabilities: ₹23,964.19 lakhs

Cash Flow (Standalone) for H1 FY27

  • Net Cash from Operating Activities: (₹1,171.35) lakhs outflow
  • Net Cash used in Investing Activities: (₹105.07) lakhs outflow
  • Net Cash from Financing Activities: ₹304.21 lakhs inflow
  • Net Decrease in Cash: (₹972.21) lakhs
  • Cash & Cash Equivalents at Period End: ₹173.06 lakhs (vs. ₹1,145.28 lakhs at year-start)

Detailed Consolidated Financial Performance (in ₹ Lakhs)

Quarterly Performance (Consolidated)

  • Revenue from Operations: ₹8,884.70 in Q2 FY27 vs. ₹7,720.79 in Q2 FY26.
  • Profit After Tax (Attributable to Owners): ₹740.95 in Q2 FY27 vs. ₹628.96 in Q2 FY26.
  • Basic & Diluted EPS (₹): 3.81 in Q2 FY27 vs. 3.23 in Q2 FY26.

Half-Yearly Performance (Consolidated)

  • Revenue from Operations: ₹15,888.73 in H1 FY27 vs. ₹13,799.49 in H1 FY26.
  • Profit After Tax (Attributable to Owners): ₹1,310.72 in H1 FY27 vs. ₹1,015.75 in H1 FY26.
  • Basic & Diluted EPS (₹): 6.74 in H1 FY27 vs. 5.23 in H1 FY26.

Key Consolidated Balance Sheet Items as of September 30, 2026

  • Total Assets: ₹71,515.91 lakhs
  • Total Equity: ₹47,454.02 lakhs (Attributable to owners: ₹47,441.90 lakhs)

Notes to Financial Results

  • Exceptional Items: An exceptional income of ₹1,953.77 lakhs was recorded due to a reversal of gratuity expense following an amendment to the company's gratuity scheme to align with the Payment of Gratuity Act, 1972. This is presented as a separate line item due to its material and non-recurring nature.
  • Employee Stock Option Scheme (ESOP): Employee benefit expense includes a charge of ₹663.16 lakhs for the quarter and ₹1,319.13 lakhs for the half-year towards equity-settled share-based payments. The impact of ESOPs has been considered in the calculation of Basic and Diluted EPS.
  • Segment Information: The company operates primarily in one reportable segment: Health and Hygiene products and services.
  • Auditor's Review: The financial results have been subjected to a limited review by the statutory auditors, Deloitte Haskins & Sells LLP, who issued an unmodified review conclusion.
  • Subsidiaries: The consolidated results include the financials of subsidiaries: Infinite Water Solutions Pvt. Ltd., ForbesAquatech Ltd., Euro Forbes Ltd., and Forbes Lux FZE (up to November 13, 2025). The review report relies on the reports of other auditors for one material subsidiary.

Director Re-appointment Details

  • Director Name: Mr. Homi Katgara
  • DIN: 00210338
  • Nature of Change: Re-appointment as Non-Executive, Independent Director.
  • Term: Second term of 5 consecutive years, from January 31, 2027, to January 30, 2032.
  • Profile: Mr. Katgara is a Partner in Jeena & Company, a freight forwarding firm, with over 43 years of experience. He holds directorships in other Jeena Group companies and is an Independent Director at Quantum Trustee Company. He is also the Managing Trustee of Masina Hospital.
  • Relationships: He is not related to any other director of the company.
  • Eligibility: He is not debarred from holding the office of director by any SEBI or other authority order.